Open AccessA Combination Strategy of Ceftriaxone, Sulbactam and Disodium Edetate for the Treatment of Multi-Drug Resistant (MDR) Septicaemia: A Retrospective, Observational Study in Indian Tertiary Care Hospital
Author(s) -
Umakant N Patil,
Kiran Lakkol Jambulingappa
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/14129.6840
Subject(s) - medicine , ceftriaxone , sulbactam , antibiotics , retrospective cohort study , cephalosporin , surgery , antibiotic resistance , microbiology and biotechnology , imipenem , biology
Previous studies have suggested the use of rational combination therapy for the treatment of multi-drug resistant (MDR) infections. An antibiotic adjuvant entity (AAE) of ceftriaxone, sulbactam and disodium edetate (Elores) was approved for multi-drug resistant infections in India.